BECN1 and hepatocellular carcinoma: Also, Yuan et al. reported increased therapeutic effects of sorafenib for HCC treatment using its combination therapy with 3‐Methyladenine (3‐MA), an autophagy inhibitor, or a small interfering RNA (siRNA)‐specific for inhibiting Beclin1.178